Area of research
Reproductive Medicine · Genetics
Research interest
Research interests include Ovarian cancer diagnosis and treatment, BRCA gene mutations in cancer, PARP inhibition in cancer therapy, and Endometrial and Cervical Cancer Treatments.
Genomically matched therapy in advanced solid tumors: the randomized phase 2 ROME trial
Efficacy and safety of dostarlimab in combination with chemotherapy in patients with dMMR/MSI-H primary advanced or recurrent endometrial cancer in a phase 3, randomized, placebo-controlled trial (ENGOT-EN6-NSGO/GOG-3031/RUBY)
Real world data of niraparib in platinum sensitive relapsed ovarian cancer: A multicenter experience of the MITO group
733 Real world data of niraparib in platinum sensitive relapsed ovarian cancer: a multicenter experience of the MITO group
Impact of COVID-19 in gynecologic oncology: a Nationwide Italian Survey of the SIGO and MITO groups
23 Impact of COVID-19 in gynecologic oncology: a nationwide Italian survey
Association of Type and Location of<i>BRCA1</i>and<i>BRCA2</i>Mutations With Risk of Breast and Ovarian Cancer